Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker YKL40

Details for Australian Patent Application No. 2009207923 (hide)

Owner Rigshospitalet

Inventors Kastrup, Jens

Agent FB Rice

Pub. Number AU-A-2009207923

PCT Pub. Number WO2009/092382

Priority PA 2008 00089 23.01.08 DK

Filing date 22 January 2009

Wipo publication date 30 July 2009

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/58 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving labelled substances

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

5 August 2010 PCT application entered the National Phase

  PCT publication WO2009/092382 Priority application(s): WO2009/092382

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009207926-A new metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression

2009207922-YKL-40 as a general marker for nonspecific disease